Published in Neuropsychiatr Dis Treat on October 29, 2010
Inter-relationships between isotretinoin treatment and psychiatric disorders: Depression, bipolar disorder, anxiety, psychosis and suicide risks. World J Psychiatry (2015) 0.81
A Case Report of Isotretinoin-induced Manic Psychosis. Indian J Dermatol (2016) 0.75
The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry (1998) 65.11
A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry (1978) 25.54
Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol (1998) 2.77
Antidepressant treatment of psychotic major depression: potential role of the sigma receptor. CNS Spectr (2005) 1.70
The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry (2010) 1.61
Pharmacology and therapeutic potential of sigma(1) receptor ligands. Curr Neuropharmacol (2008) 1.55
Affective psychosis following Accutane (isotretinoin) treatment. Int Clin Psychopharmacol (2005) 1.35
The neurobiology of retinoic acid in affective disorders. Prog Neuropsychopharmacol Biol Psychiatry (2007) 1.25
Isotretinoin and psychopathology: a review. Ann Gen Psychiatry (2009) 1.16
Isotretinoin and the controversy of psychiatric adverse effects. Int J Dermatol (2006) 1.05
Psychiatric reactions to isotretinoin in patients with bipolar disorder. J Affect Disord (2009) 1.04
Obsessive-compulsive disorder and related disorders: a comprehensive survey. Ann Gen Psychiatry (2009) 1.01
Isotretinoin treatment of a woman with bipolar disorder. J Clin Psychiatry (1999) 0.94
Dimensional structure of the Yale-Brown Obsessive-Compulsive Scale (Y-BOCS). Psychiatry Res (2002) 0.93
Olanzapine augmentation of fluvoxamine-refractory obsessive-compulsive disorder (OCD): a 12-week open trial. Psychiatry Res (2000) 0.92
Validating Kraepelin's two types of depressive mixed states: "depression with flight of ideas" and "excited depression". World J Biol Psychiatry (2004) 0.91
Serotonin and dopamine antagonism in obsessive-compulsive disorder: effect of atypical antipsychotic drugs. Pharmacopsychiatry (2000) 0.90
Sigma receptors and sigma ligands: background to a pharmacological enigma. Pharmacopsychiatry (2004) 0.87
The sigma enigma: can sigma receptors provide a novel target for disorders of mood and cognition? J Clin Psychiatry (2008) 0.86
Aripiprazole augmentation in poor insight obsessive-compulsive disorder: a case report. Ann Gen Psychiatry (2008) 0.85
The "Dorian Gray Syndrome": psychodynamic need for hair growth restorers and other "fountains of youth.". Int J Clin Pharmacol Ther (2001) 0.82
Juvenile stress attenuates the dorsal hippocampal postsynaptic 5-HT1A receptor function in adult rats. Psychopharmacology (Berl) (2010) 0.80
[Psychiatric symptoms during isotretinoin therapy]. Ned Tijdschr Geneeskd (2003) 0.80
Augmentation strategy with olanzapine in resistant obsessive compulsive disorder: an Italian long-term open-label study. J Psychopharmacol (2005) 0.79